Skip to content

SPECT/CT in the Diagnosis of Dementia

SPECT/CT in the Diagnosis of Dementia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01112501
Acronym
DEMSPET
Enrollment
82
Registered
2010-04-28
Start date
2006-09-30
Completion date
2010-01-31
Last updated
2010-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia

Keywords

Diagnosis, Dementia, Imaging

Brief summary

Aim of the study is to evaluate whether Tc-99m-ECD-SPECT/CT enhances early diagnosis of dementia in two specific patient groups: (1) patient with mild cognitive impairment, and (2) patient with possible symptoms and signs of frontotemporal dementia. Evaluation of SPECT/CT data is performed both by visual and quantitative voxel-based analyses (Statistical Parametric Mapping). The final diagnosis is based on up to four years clinical follow-up.

Interventions

None listed

Sponsors

University of Eastern Finland
CollaboratorOTHER
Kuopio University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

(one of these): * healthy control * mild cognitive impairment (recruited from a population based data) * clinically suspected frontotemporal dementia (unset diagnosis)

Exclusion criteria

* unable to be scanned with SPECT/CT

Design outcomes

Primary

MeasureTime frameDescription
Final diagnosis4 years(1) controls, (2) stable mild cognitive impairment (MCI), (3)MCI converted to Alzheimers's disease (AD), (4) frontotemporal dementia (FTD), suspected FTD converted to AD, (5) other final diagnoses

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026